Alseres enters contract with Navidea to license Altropane imaging agent Alseres Pharmaceuticals, Inc http://kamagra-en-france.net/ click here . today announced that it offers entered into an agreement with Navidea Biopharmaceuticals, Inc. We are very happy to have completed this agreement with Navidea. Savas, CEO of Alseres. The diagnostic dilemma in motion disorders remains a pressing medical want that will continue steadily to escalate as our world’s population ages, said Dr. Tag Pykett, President and CEO of Navidea. The addition of the CFT plan is consistent with our growth strategy to build our accuracy radiopharmaceutical pipeline with later stage, high value diagnostics targeted at important medical requirements. Thomas Tulip, Navidea’ s EVP and Chief Business Officer.